The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study involved roughly 800 elderly men with low testosterone and symptoms related to this illness, like http://tinyurl.com/zj86oxg
physical and sexual dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.
The recent contradictory findings on testosterone therapy prompted Patel and his team to run a sizeable systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated
13 million men in the United States suffer from low testosterone, which occurs when the body does not make enough hormones because of a difficulty with the testicles or pituitary gland. This describes the sudden weight gain, apparent aging and decline of energy of an individual.
And many women have a knee jerk feeling that any hormone treatment can raise their risk of breast cancer
. However, clinical studies demonstrate that testosterone not only does not raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will likely stay the status quo for some time, given the prohibitive cost of running the long term safety studies needed to gain FDA acceptance that is more total.